SNDX - Syndax down 4% prices $200M equity offering
2023-12-15 05:15:59 ET
More on Syndax Pharmaceuticals
- Syndax: Biotech To Watch With Regulatory Filings Before End Of 2023
- Syndax announces proposed $150M public offering of common stock
- Syndax reports encouraging Phase 1 data for leukemia drug
For further details see:
Syndax down 4%, prices $200M equity offering